** = Publications listed in SCI/SSCI/Pubmed
** Veltkamp, R; Korompoki, E; Harvey, KH; Harvey, ER; Fießler, C; Malzahn, U; Rücker, V; Montaner, J; Caso, V; Sibon, I; Ringleb, P; Halse, O; Hügen, K; Ullmann, S; Schuhmann, C; Todd, GP; Haas, K; Palà, E; Debette, S; Lachaize, M; D'Aoust, T; Enzinger, C; Ropele, S; Fandler-Höfler, S; Haidegger, M; Wang, Y; Wafa, HA; Cancelloni, V; Mosconi, MG; Lip, GYH; Lane, DA; Haefeli, WE; Foerster, KI; Wurmbach, VS; Nielsen, PB; Hajjar, K; Müller, P; Poli, S; Purrucker, J; Laible, M; D'Anna, L; Silva, Y; de, Torres, Chacon, R; Martínez-Sánchez, P; Boulanger, M; Norrving, B; Paré, G; Wachter, R; Ntaios, G; Wolfe, CDA; Heuschmann, PU, , PRESTIGE-AF, Consortium
Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.
Lancet. 2025; 405(10482):927-936
Doi: 10.1016/S0140-6736(25)00333-2
Web of Science
PubMed
FullText
FullText_MUG